1. Avalon GloboCare acquires RPM Interactive for AI technology. 2. Catch-Up SaaS platform generates videos without manual editing. 3. Aims to enhance marketing for KetoAir™ breathalyzer device. 4. Upcoming merger with YOOV Group under SEC review.
FAQ
Why Bullish?
The acquisition of RPM enhances ALBT's innovative capabilities and could generate significant new revenue streams, similar to positive market reactions seen during similar strategic acquisitions in tech industries.
How important is it?
New AI capabilities from the RPM acquisition and strategic initiatives for the KetoAir™ device signal growth potential, making the article highly relevant.
Why Long Term?
As the Catch-Up platform develops and commercializes, its long-term potential can substantially influence revenue, echoing success stories like Zoom and Microsoft Teams post-acquisition in the SaaS domain.
Avalon GloboCare Acquires RPM Interactive, Enhancing AI Video Capabilities
FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) - Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a leader in precision diagnostic consumer products, has announced a significant development through its acquisition of RPM Interactive, Inc. (“RPM”). This acquisition was highlighted in an interview with Michael Mathews, a member of Avalon’s Board of Directors and CEO of RPM, on ProactiveInvestors.com. The interview provided insights into the innovative Catch-Up platform developed by RPM.
Catch-Up Platform: Revolutionizing Video Creation
Mr. Mathews elaborated on the Catch-Up platform, emphasizing its capabilities as a Software as a Service (SaaS) solution that can automatically generate videos utilizing generative AI technologies and large language models. This platform is set to transform how content is created across various sectors.
- Target Users: Content creators, media organizations, and brands.
- Functionality: Efficiently produces recap-style videos spanning categories such as news, politics, sports, finance, and entertainment.
- Benefits: Eliminates the need for manual editing, advanced production tools, or technical expertise, enabling higher video output for users.
Marketing Strategies and Future Developments
Avalon plans to leverage the Catch-Up platform for enhancing marketing initiatives surrounding its FDA-registered KetoAir™ breathalyzer, designed to assist consumers in managing their wellness and metabolic health. This strategic utilization is expected to amplify the reach and effectiveness of Avalon’s marketing efforts.
The platform is intended to not only serve as a valuable tool for content generation but also as a crucial element in promoting Avalon’s health-focused products and innovations, showcasing the Company’s commitment to integrating advanced technology with health management solutions.
About Avalon GloboCare Corp. (NASDAQ: ALBT)
Avalon GloboCare Corp. specializes in the development of precision diagnostic consumer products and the advancement of cellular therapy intellectual property. Besides the KetoAir™ breathalyzer, which is recognized as a Class I medical device by the U.S. Food and Drug Administration, the Company actively works on expanding its patent portfolio and has interests in commercial real estate.
For further information about Avalon GloboCare, visit www.avalon-globocare.com.
Forward-Looking Statements
This announcement may contain “forward-looking statements” that are subject to various uncertainties and risks. Such statements are based on current expectations regarding future events and should be viewed with caution. Actual outcomes may vary significantly due to numerous factors as disclosed in the Company’s SEC filings.
It is crucial for investors and stakeholders to remain informed regarding developments concerning Avalon and RPM, including forthcoming materials related to their merger with YOOV Group Holding Limited. Key documents can be accessed freely through the U.S. Securities and Exchange Commission’s website at www.sec.gov.